These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 27369586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety evaluation of orally administered afoxolaner and milbemycin oxime in eight-week-old dogs.
    Drag M, Saik J, Harriman J, Letendre L, Yoon S, Larsen D.
    J Vet Pharmacol Ther; 2017 Oct; 40(5):447-453. PubMed ID: 27891622
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA.
    Becskei C, Kryda K, Fias D, Follis SL, Wozniakiewicz M, Mahabir SP, Farkas R.
    Parasit Vectors; 2020 Mar 01; 13(1):70. PubMed ID: 32113470
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of milbemycin oxime/afoxolaner chewable tablets (NEXGARD SPECTRA®) against Capillaria aerophila and Capillaria boehmi in naturally infected dogs.
    Di Cesare A, Morelli S, Morganti G, Simonato G, Veronesi F, Colombo M, Berlanda M, Lebon W, Gallo M, Beugnet F, Traversa D.
    Parasit Vectors; 2021 Mar 06; 14(1):143. PubMed ID: 33676579
    [Abstract] [Full Text] [Related]

  • 18. Dose confirmation and non-interference evaluations of the oral efficacy of a combination of milbemycin oxime and spinosad against the dose limiting parasites, adult cat flea (Ctenocephalides felis) and hookworm (Ancylostoma caninum), in dogs.
    Snyder DE, Wiseman S.
    Vet Parasitol; 2012 Mar 23; 184(2-4):284-90. PubMed ID: 22226761
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of a single oral administration of milbemycin oxime against natural infections of Ancylostoma braziliense in dogs.
    Bienhoff SE, Kok DJ, Roycroft LM, Roberts ES.
    Vet Parasitol; 2013 Jul 01; 195(1-2):102-5. PubMed ID: 23375194
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of afoxolaner or the combination of afoxolaner with milbemycin oxime against Otodectes cynotis in naturally infested dogs.
    Sioutas G, Papadopoulos E, Madder M, Beugnet F, Tielemans E.
    Vet Parasitol; 2024 Feb 01; 326():110108. PubMed ID: 38154391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.